TARSUS PHARMACEUTICALS INC (TARS)

Stay updated with the stocks that are on the move in today's after-hours session.

Top movers in Wednesday's after hours session

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter Strengthened payer...

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes IRVINE, Calif.,...

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024

IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven...

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization

Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer

Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization...

First Week of TARS December 20th Options Trading

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%

Campaign showcases root cause of Demodex blepharitis through creative representation of mischief-causing mites on patients’ eyelids Demodex blepharitis...

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024

IRVINE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven...

Tarsus Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for TARS

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

IRVINE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven...

TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tarsus Pharmaceuticals (NASDAQ:TARS) just reported results for the second quart...

Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven...

RSI Alert: Tarsus Pharmaceuticals Now Oversold

Interesting TARS Put And Call Options For September 20th

TARS Crosses Below Key Moving Average Level

Tarsus Pharmaceuticals (TARS) Shares Cross Below 200 DMA

First Week of August 16th Options Trading For Tarsus Pharmaceuticals (TARS)

Tarsus Pharmaceuticals is Now Oversold (TARS)

Investors Snag TARS Even Cheaper Than Its Secondary Stock Offering

Tarsus to Participate in Upcoming Investor Conferences

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven...

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference

IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman, will participate in an in-person fireside chat at the 2024 Bank of America Healthcare Conference taking place in Las Vegas, NV, on Wednesday, May 15, at 1:55 p.m. PT / 4:55 p.m. ET.